1887

Journal of General Virology header logo

Volume 97, Issue 2

End-point disease investigation for virus strains of intermediate virulence as illustrated by flavivirus infections Free

Abstract

Viruses of intermediate virulence are defined as isolates causing an intermediate morbidity/mortality rate in a specific animal model system, involving specific host and inoculation parameters (e.g. dose and route). Therefore, variable disease phenotype may exist between animals that develop severe disease or die and those that are asymptomatic or survive after infection with these isolates. There may also be variability amongst animals within each of these subsets. Such potential variability may confound the use of time-point sacrifice experiments to investigate pathogenesis of this subset of virus strains, as uniformity in disease outcome is a fundamental assumption for time-course sacrifice experiments. In the current study, we examined the disease phenotype, neuropathology, neural infection and glial cell activity in moribund/dead and surviving Swiss white (CD-1) mice after intraperitoneal infection with various Australian flaviviruses, including West Nile virus (WNV) strains of intermediate virulence (WNV and WNV), and highly virulent Murray Valley encephalitis virus (MVEV) isolates. We identified notable intragroup variation in the end-point disease in mice infected with either WNV strain, but to a lesser extent in mice infected with MVEV strains. The variable outcomes associated with WNV infection suggest that pathogenesis investigations using time-point sacrifice of WNV-infected mice may not be the best approach, as the assumption of uniformity in outcomes is violated. Our study has therefore highlighted a previously unacknowledged challenge to investigating pathogenesis of virus isolates of intermediate virulence. We have also set a precedent for routine examination of the disease phenotype in moribund/dead and surviving mice during survival challenge experiments.

  • Received:
  • Accepted:
  • Published Online:
© 2015 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000356
2016-02-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/2/366.html?itemId=/content/journal/jgv/10.1099/jgv.0.000356&mimeType=html&fmt=ahah

References

  1. Adams S. C., Broom A. K., Sammels L. M., Hartnett A. C., Howard M. J., Coelen R. J., Mackenzie J. S., Hall R. A. 1995; Glycosylation and antigenic variation among Kunjin virus isolates. Virology 206:49–56 [View Article][PubMed]
     [Google Scholar]
  2. Angenvoort J., Brault A. C., Bowen R. A., Groschup M. H. 2013; West Nile viral infection of equids. Vet Microbiol 167:168–180 [View Article][PubMed]
     [Google Scholar]
  3. Beasley D. W., Li L., Suderman M. T., Barrett A. D. 2002; Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology 296:17–23 [View Article][PubMed]
     [Google Scholar]
  4. Bielefeldt-Ohmann H., Smirnova N. P., Tolnay A. E., Webb B. T., Antoniazzi A. Q., van Campen H., Hansen T. R. 2012; Neuro-invasion by a ‘Trojan Horse’ strategy and vasculopathy during intrauterine flavivirus infection. Int J Exp Pathol 93:24–33 [View Article][PubMed]
     [Google Scholar]
  5. Bingham J., Payne J., Harper J., Frazer L., Eastwood S., Wilson S., Lowther S., Lunt R., Warner S., other authors. 2014; Evaluation of a mouse model for the West Nile virus group for the purpose of determining viral pathotypes. J Gen Virol 95:1221–1232 [View Article][PubMed]
     [Google Scholar]
  6. Clark D. C., Lobigs M., Lee E., Howard M. J., Clark K., Blitvich B. J., Hall R. A. 2007; In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein. J Gen Virol 88:1175–1183 [View Article][PubMed]
     [Google Scholar]
  7. Contag C. H., Bachmann M. H. 2002; Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 4:235–260 [View Article][PubMed]
     [Google Scholar]
  8. Cross R. W., Fenton K. A., Geisbert J. B., Ebihara H., Mire C. E., Geisbert T. W. 2015a; Comparison of the pathogenesis of the Angola and Ravn strains of Marburg Virus in the outbred guinea pig model. J Infect Dis 212:(Suppl 2)S258–S270 [View Article][PubMed]
     [Google Scholar]
  9. Cross R. W., Fenton K. A., Geisbert J. B., Mire C. E., Geisbert T. W. 2015b; Modeling the disease course of Zaire ebolavirus Infection in the outbred guinea pig. J Infect Dis 212:(Suppl 2)S305–S315 [View Article][PubMed]
     [Google Scholar]
  10. Donadieu E., Lowenski S., Servely J. L., Laloy E., Lilin T., Nowotny N., Richardson J., Zientara S., Lecollinet S., Coulpier M. 2013; Comparison of the neuropathology induced by two West Nile virus strains. PLoS One 8:e84473 [View Article][PubMed]
     [Google Scholar]
  11. Fratkin J. D., Leis A. A., Stokic D. S., Slavinski S. A., Geiss R. W. 2004; Spinal cord neuropathology in human West Nile virus infection. Arch Pathol Lab Med 128:533–537[PubMed]
     [Google Scholar]
  12. Frost M. J., Zhang J., Edmonds J. H., Prow N. A., Gu X., Davis R., Hornitzky C., Arzey K. E., Finlaison D., other authors. 2012; Characterization of virulent West Nile virus Kunjin strain, Australia, 2011. Emerg Infect Dis 18:792–800 [View Article][PubMed]
     [Google Scholar]
  13. Garcia-Tapia D., Hassett D. E., Mitchell W.J., Jr, Johnson G. C., Kleiboeker S. B. 2007; West Nile virus encephalitis: sequential histopathological and immunological events in a murine model of infection. J Neurovirol 13:130–138 [View Article][PubMed]
     [Google Scholar]
  14. Graham J. B., Thomas S., Swarts J., McMillan A. A., Ferris M. T., Suthar M. S., Treuting P. M., Ireton R., Gale M. Jr, Lund J. M. 2015; Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes. MBio 6:e00493–e00415 [View Article][PubMed]
     [Google Scholar]
  15. Guarner J., Shieh W. J., Hunter S., Paddock C. D., Morken T., Campbell G. L., Marfin A. A., Zaki S. R. 2004; Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol 35:983–990 [View Article][PubMed]
     [Google Scholar]
  16. Jubelt B., Gallez-Hawkins G., Narayan O., Johnson R. T. 1980; Pathogenesis of human poliovirus infection in mice. I. Clinical and pathological studies. J Neuropathol Exp Neurol 39:138–148 [View Article][PubMed]
     [Google Scholar]
  17. Lobigs M., Marshall I. D., Weir R. C., Dalgarno L. 1986; Genetic differentiation of Murray Valley encephalitis virus in Australia and Papua New Guinea. Aust J Exp Biol Med Sci 64:571–585 [View Article][PubMed]
     [Google Scholar]
  18. Lobigs M., Marshall I. D., Weir R. C., Dalgarno L. 1988; Murray Valley encephalitis virus field strains from Australia and Papua New Guinea: studies on the sequence of the major envelope protein gene and virulence for mice. Virology 165:245–255 [View Article][PubMed]
     [Google Scholar]
  19. Mandl J. N., Liou R., Klauschen F., Vrisekoop N., Monteiro J. P., Yates A. J., Huang A. Y., Germain R. N. 2012; Quantification of lymph node transit times reveals differences in antigen surveillance strategies of naive CD4+ and CD8+T cells. Proc Natl Acad Sci U S A 109:18036–18041 [View Article][PubMed]
     [Google Scholar]
  20. Mandl J. N., Torabi-Parizi P., Germain R. N. 2014; Visualization and dynamic analysis of host-pathogen interactions. Curr Opin Immunol 29:8–15 [View Article][PubMed]
     [Google Scholar]
  21. McMinn P. C., Dalgarno L., Weir R. C. 1996; A comparison of the spread of Murray Valley encephalitis viruses of high or low neuroinvasiveness in the tissues of Swiss mice after peripheral inoculation. Virology 220:414–423 [View Article][PubMed]
     [Google Scholar]
  22. Miura T. A., Travanty E. A., Oko L., Bielefeldt-Ohmann H., Weiss S. R., Beauchemin N., Holmes K. V. 2008; The spike glycoprotein of murine coronavirus MHV-JHM mediates receptor-independent infection and spread in the central nervous systems of Ceacam1a − / −  mice. J Virol 82:755–763 [View Article][PubMed]
     [Google Scholar]
  23. Monath T. P., Cropp C. B., Bowen G. S., Kemp G. E., Mitchell C. J., Gardner J. J. 1980; Variation in virulence for mice and rhesus monkeys among St. Louis encephalitis virus strains of different origin. Am J Trop Med Hyg 29:948–962[PubMed]
     [Google Scholar]
  24. Morrey J. D., Siddharthan V., Wang H., Hall J. O. 2012; Respiratory insufficiency correlated strongly with mortality of rodents infected with West Nile virus. PLoS One 7:e38672 [View Article][PubMed]
     [Google Scholar]
  25. Mucker E. M., Chapman J., Huzella L. M., Huggins J. W., Shamblin J., Robinson C. G., Hensley L. E. 2015; Susceptibility of marmosets (Callithrix jacchus) to monkeypox virus: a low dose prospective model for monkeypox and smallpox disease. PLoS One 10:e0131742 [View Article][PubMed]
     [Google Scholar]
  26. Nagata N., Iwata-Yoshikawa N., Hayasaka D., Sato Y., Kojima A., Kariwa H., Takashima I., Takasaki T., Kurane I., other authors. 2015; The pathogenesis of 3 neurotropic flaviviruses in a mouse model depends on the route of neuroinvasion after viremia. J Neuropathol Exp Neurol 74:250–260 [View Article][PubMed]
     [Google Scholar]
  27. Paxinos G., Franklin K. B. J. 2004 The Mouse Brain in Stereotaxis Coordinates London: Elsevier;
     [Google Scholar]
  28. Petersen L. R., Brault A. C., Nasci R. S. 2013; West Nile virus: review of the literature. JAMA 310:308–315 [View Article][PubMed]
     [Google Scholar]
  29. Pol J. M., Gielkens A. L., van Oirschot J. T. 1989; Comparative pathogenesis of three strains of pseudorabies virus in pigs. Microb Pathog 7:361–371 [View Article][PubMed]
     [Google Scholar]
  30. Prow N. A., May F. J., Westlake D. J., Hurrelbrink R. J., Biron R. M., Leung J. Y., McMinn P. C., Clark D. C., Mackenzie J. S., other authors. 2011; Determinants of attenuation in the envelope protein of the flavivirus Alfuy. J Gen Virol 92:2286–2296 [View Article][PubMed]
     [Google Scholar]
  31. Prow N. A., Setoh Y. X., Biron R. M., Sester D. P., Kim K. S., Hobson-Peters J., Hall R. A., Bielefeldt-Ohmann H. 2014; The West Nile virus-like flavivirus Koutango is highly virulent in mice due to delayed viral clearance and the induction of a poor neutralizing antibody response. J Virol 88:9947–9962 [View Article][PubMed]
     [Google Scholar]
  32. Rautenschlein S., Yeh H. Y., Sharma J. M. 2003; Comparative immunopathogenesis of mild, intermediate, and virulent strains of classic infectious bursal disease virus. Avian Dis 47:66–78 [View Article][PubMed]
     [Google Scholar]
  33. Segar T. M., Kasckow J. W., Welge J. A., Herman J. P. 2009; Heterogeneity of neuroendocrine stress responses in aging rat strains. Physiol Behav 96:6–11 [View Article][PubMed]
     [Google Scholar]
  34. Shrestha B., Gottlieb D., Diamond M. S. 2003; Infection and injury of neurons by West Nile encephalitis virus. J Virol 77:13203–13213 [View Article][PubMed]
     [Google Scholar]
  35. Tolnay A. E., Baskin C. R., Tumpey T. M., Sabourin P. J., Sabourin C. L., Long J. P., Pyles J. A., Albrecht R. A., García-Sastre A., other authors. 2010; Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus. Arch Virol 155:905–914 [View Article][PubMed]
     [Google Scholar]
  36. Zhao K., Gu M., Zhong L., Duan Z., Zhang Y., Zhu Y., Zhao G., Zhao M., Chen Z., other authors. 2013; Characterization of three H5N5 and one H5N8 highly pathogenic avian influenza viruses in China. Vet Microbiol 163:351–357 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000356
Loading
End-point disease investigation for virus strains of intermediate virulence as illustrated by flavivirus infections
J. Gen. Virol. 97, 366 (2016); https://doi.org/10.1099/jgv.0.000356
/content/journal/jgv/10.1099/jgv.0.000356
/content/journal/jgv/10.1099/jgv.0.000356
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error